Revenue: The sum of all revenue fields included for a company's operating activities.
Myriad Genetics, Inc. (MYGN) had Revenue of $213.10M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$213.10M |
$-330.50M |
|
$61.30M |
|
$151.80M |
|
$542.30M |
|
$-329.20M |
|
$-1.40M |
|
$-330.60M |
|
$-330.60M |
|
$-330.50M |
|
$-330.50M |
|
$-330.50M |
|
$-330.50M |
|
$-329.20M |
|
$1.60M |
|
92.50M |
|
92.50M |
|
$-3.57 |
|
$-3.57 |
|
| Balance Sheet Financials | |
$284.30M |
|
$113.00M |
|
$393.00M |
|
$677.30M |
|
$199.90M |
|
-- |
|
$89.30M |
|
$289.20M |
|
$388.10M |
|
$166.40M |
|
$388.10M |
|
93.10M |
|
| Cash Flow Statement Financials | |
$-29.90M |
|
$-15.20M |
|
$16.20M |
|
$111.90M |
|
$83.70M |
|
$-28.20M |
|
$20.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.42 |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
71.23% |
|
-154.48% |
|
-154.48% |
|
-- |
|
-155.14% |
|
-155.09% |
|
$-38.00M |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
2.14 |
|
1.56 |
|
57.86 |
|
-85.16% |
|
-198.62% |
|
-48.80% |
|
-85.16% |
|
$4.17 |
|
$-0.41 |
|
$-0.32 |
|